1. Home
  2. NVEC vs TNGX Comparison

NVEC vs TNGX Comparison

Compare NVEC & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NVE Corporation

NVEC

NVE Corporation

HOLD

Current Price

$70.73

Market Cap

328.9M

Sector

Technology

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$9.32

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVEC
TNGX
Founded
1989
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
328.9M
1.4B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NVEC
TNGX
Price
$70.73
$9.32
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$12.50
AVG Volume (30 Days)
50.0K
2.6M
Earning Date
01-21-2026
11-04-2025
Dividend Yield
5.67%
N/A
EPS Growth
N/A
N/A
EPS
2.85
N/A
Revenue
$24,784,396.00
$66,501,000.00
Revenue This Year
N/A
$53.01
Revenue Next Year
N/A
N/A
P/E Ratio
$25.72
N/A
Revenue Growth
N/A
53.29
52 Week Low
$51.50
$1.03
52 Week High
$88.50
$11.20

Technical Indicators

Market Signals
Indicator
NVEC
TNGX
Relative Strength Index (RSI) 61.79 52.39
Support Level $62.71 $8.89
Resistance Level $66.26 $10.22
Average True Range (ATR) 2.16 0.63
MACD 1.25 -0.14
Stochastic Oscillator 77.96 20.91

Price Performance

Historical Comparison
NVEC
TNGX

About NVEC NVE Corporation

NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: